182 related articles for article (PubMed ID: 34132375)
1. Silencing of the long noncoding RNA LINC01132 alleviates the oncogenicity of epithelial ovarian cancer by regulating the microRNA‑431‑5p/SOX9 axis.
Zhu W; Xiao X; Chen J
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132375
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis.
Gao H; Li X; Zhan G; Zhu Y; Yu J; Wang J; Li L; Wu W; Liu N; Guo X
Cell Cycle; 2019 Jun; 18(12):1393-1406. PubMed ID: 31122127
[TBL] [Abstract][Full Text] [Related]
4. Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
Li R; Wang Y; Xu Y; He X; Li Y
Int J Oncol; 2019 Nov; 55(5):1110-1124. PubMed ID: 31545411
[TBL] [Abstract][Full Text] [Related]
5. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
[TBL] [Abstract][Full Text] [Related]
7. Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis.
Tan Y; Xu F; Xu L; Cui J
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970695
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer.
Hua F; Li CH; Chen XG; Liu XP
Oncol Res; 2018 Mar; 26(2):241-247. PubMed ID: 28550684
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
[TBL] [Abstract][Full Text] [Related]
11. LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis.
Liu S; Xi X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1088-1094. PubMed ID: 33036757
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
14. LncRNA
Wang J; Han Y; Zhang T; Li J; Xu B
Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1/DPP4 axis in hepatocellular carcinoma.
Zhang J; Pan T; Zhou W; Zhang Y; Xu G; Xu Q; Li S; Gao Y; Wang Z; Xu J; Li Y
J Exp Clin Cancer Res; 2022 Sep; 41(1):270. PubMed ID: 36071454
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b.
Zhang F; Luo BH; Wu QH; Li QL; Yang KD
Mol Med; 2022 Jan; 28(1):2. PubMed ID: 34983361
[TBL] [Abstract][Full Text] [Related]
18. miR-200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice.
Yang C; Li H; Zhang T; Chu Y; Chen D; Zuo J
J Cell Biochem; 2020 Feb; 121(2):1514-1523. PubMed ID: 31535411
[TBL] [Abstract][Full Text] [Related]
19. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
He S; Wang X; Zhang J; Zhou F; Li L; Han X
Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]